Literature DB >> 25006249

Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.

Fabiana N Soki1, Amy J Koh1, Jacqueline D Jones1, Yeo Won Kim1, Jinlu Dai2, Evan T Keller2, Kenneth J Pienta3, Kamran Atabai4, Hernan Roca1, Laurie K McCauley5.   

Abstract

Tumor cells secrete factors that modulate macrophage activation and polarization into M2 type tumor-associated macrophages, which promote tumor growth, progression, and metastasis. The mechanisms that mediate this polarization are not clear. Macrophages are phagocytic cells that participate in the clearance of apoptotic cells, a process known as efferocytosis. Milk fat globule- EGF factor 8 (MFG-E8) is a bridge protein that facilitates efferocytosis and is associated with suppression of proinflammatory responses. This study investigated the hypothesis that MFG-E8-mediated efferocytosis promotes M2 polarization. Tissue and serum exosomes from prostate cancer patients presented higher levels of MFG-E8 compared with controls, a novel finding in human prostate cancer. Coculture of macrophages with apoptotic cancer cells increased efferocytosis, elevated MFG-E8 protein expression levels, and induced macrophage polarization into an alternatively activated M2 phenotype. Administration of antibody against MFG-E8 significantly attenuated the increase in M2 polarization. Inhibition of STAT3 phosphorylation using the inhibitor Stattic decreased efferocytosis and M2 macrophage polarization in vitro, with a correlating increase in SOCS3 protein expression. Moreover, MFG-E8 knockdown tumor cells cultured with wild-type or MFG-E8-deficient macrophages resulted in increased SOCS3 expression with decreased STAT3 activation. This suggests that SOCS3 and phospho-STAT3 act in an inversely dependent manner when stimulated by MFG-E8 and efferocytosis. These results uncover a unique role of efferocytosis via MFG-E8 as a mechanism for macrophage polarization into tumor-promoting M2 cells.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alternative Activation; Bone; Bone Marrow; Efferocytosis; MFG-E8; Macrophage; Phagocytosis; Prostate Cancer; Skeletal Metastasis; Tumor-associated Macrophages

Mesh:

Substances:

Year:  2014        PMID: 25006249      PMCID: PMC4148880          DOI: 10.1074/jbc.M114.571620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model.

Authors:  Kylie A Alexander; Ming K Chang; Erin R Maylin; Thomas Kohler; Ralph Müller; Andy C Wu; Nico Van Rooijen; Matthew J Sweet; David A Hume; Liza J Raggatt; Allison R Pettit
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

Review 2.  Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation.

Authors:  Monowar Aziz; Asha Jacob; Akihisa Matsuda; Ping Wang
Journal:  Apoptosis       Date:  2011-11       Impact factor: 4.677

Review 3.  Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues.

Authors:  Christopher D Gregory; John D Pound
Journal:  J Pathol       Date:  2010-10-25       Impact factor: 7.996

4.  Identification of a factor that links apoptotic cells to phagocytes.

Authors:  Rikinari Hanayama; Masato Tanaka; Keiko Miwa; Azusa Shinohara; Akihiro Iwamatsu; Shigekazu Nagata
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

Review 5.  A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.

Authors:  Robert D Loberg; Bishoy A Gayed; Karin B Olson; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2005-10-15       Impact factor: 4.429

Review 6.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

7.  SOCS3 deficiency promotes M1 macrophage polarization and inflammation.

Authors:  Hongwei Qin; Andrew T Holdbrooks; Yudong Liu; Stephanie L Reynolds; Lora L Yanagisawa; Etty N Benveniste
Journal:  J Immunol       Date:  2012-08-27       Impact factor: 5.422

8.  Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment.

Authors:  Masahisa Jinushi; Yukoh Nakazaki; Daniel R Carrasco; Dobrin Draganov; Nicholas Souders; Matthew Johnson; Martin C Mihm; Glenn Dranoff
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

Review 9.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.

Authors:  Ioannis D Dimitriou; Liliana Clemenza; Andrew J Scotter; Grace Chen; Fiona M Guerra; Robert Rottapel
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming.

Authors:  Marie-Joëlle Brissette; Stéphanie Lepage; Anne-Sophie Lamonde; Isabelle Sirois; Jessika Groleau; Louis-Philippe Laurin; Jean-François Cailhier
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

View more
  68 in total

Review 1.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  The skeletal impact of the chemotherapeutic agent etoposide.

Authors:  A J Koh; B P Sinder; P Entezami; L Nilsson; L K McCauley
Journal:  Osteoporos Int       Date:  2017-04-20       Impact factor: 4.507

3.  Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.

Authors:  Hernan Roca; Jacqueline D Jones; Marta C Purica; Savannah Weidner; Amy J Koh; Robert Kuo; John E Wilkinson; Yugang Wang; Stephanie Daignault-Newton; Kenneth J Pienta; Todd M Morgan; Evan T Keller; Jacques E Nör; Lonnie D Shea; Laurie K McCauley
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

4.  Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.

Authors:  Koichi Sakakura; Hideyuki Takahashi; Kyoichi Kaira; Minoru Toyoda; Takaaki Murata; Hiroshi Ohnishi; Tetsunari Oyama; Kazuaki Chikamatsu
Journal:  Lab Invest       Date:  2016-06-20       Impact factor: 5.662

5.  Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly.

Authors:  Roel P H De Maeyer; Rachel C van de Merwe; Rikah Louie; Olivia V Bracken; Oliver P Devine; Daniel R Goldstein; Mohib Uddin; Arne N Akbar; Derek W Gilroy
Journal:  Nat Immunol       Date:  2020-04-06       Impact factor: 25.606

Review 6.  Biochemical Changes in the Niche Following Tumor Cell Invasion.

Authors:  A M Decker; F C Cackowski; Y Jung; R S Taichman
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

7.  Milk Fat Globule-Epidermal Growth Factor 8 (MFG-E8) Is a Novel Anti-inflammatory Factor in Rheumatoid Arthritis in Mice and Humans.

Authors:  Elise Albus; Kathrin Sinningen; Maria Winzer; Sylvia Thiele; Ulrike Baschant; Anke Hannemann; Julia Fantana; Anne-Kathrin Tausche; Henri Wallaschofski; Matthias Nauck; Henry Völzke; Sylvia Grossklaus; Triantafyllos Chavakis; Mark C Udey; Lorenz C Hofbauer; Martina Rauner
Journal:  J Bone Miner Res       Date:  2015-11-09       Impact factor: 6.741

8.  Protective effect of MFG-E8 after cutaneous ischemia-reperfusion injury.

Authors:  Akihiko Uchiyama; Kazuya Yamada; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

9.  MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages.

Authors:  Kazuya Yamada; Akihiko Uchiyama; Akihito Uehara; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Mark C Udey; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

Review 10.  Synergistic immunologic targets for the treatment of prostate cancer.

Authors:  Karen M Doersch; Kelvin A Moses; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.